Skills

People expertise

  • Lawrence Young
    Head of ICS EBV virology, gene therapy
  • David Adams
    Clinical hepatology, dendritic cell biology, lymphocyte homing
  • Lucinda Billingham
    Statistical analysis
  • David Blackbourn
    HHV8 biology
  • Charles Craddock
    Clinical haematology, transplant immunology, epigenetics in cancer
  • Jayne Doran
    Early drug development (EDD) team leader
  • Ulrich Gunther
    NMR metabolomics
  • Nicholas James
    Clinical urology, gene therapy
  • Philip Johnson
    Head of CRCTU, proteomics
  • El-Nasir Lalani
    Professor of Pathology, tissue banking, prostate research
  • Steven Lee
    T cell adoptive therapy, T cell receptor
  • Ashely Martin
    Proteomics
  • Vivien Mautner
    Adenovirology, gene therapy
  • Dorothy MacDonald
    Head of the Stem Cell Laboratory at NBS, cellular products
  • Paul Murray
    Molecular pathology EBV
  • Michael Overduin
    Director of NMR Centre, metabolomics
  • Daniel Palmer
    Medical oncology, gene therapy
  • Christopher Poole
    Medical oncology, clinical trials
  • Emilio Porfiri
    Medical oncology, gene therapy
  • Guy Pratt
    Clinical haematology, multiple myeloma
  • Alan Rickinson
    EBV biology and immunology
  • Sally Roberts
    Papillomavirus
  • Martin Rowe
    EBV - immune evasion and cell transformation.
  • Peter Searle
    Gene therapy (VDEPT)
  • Tanya Stankovic
    DNA repair in human cancer
  • Jane Steele
    Immunotherapy - especially related to dendritic cells, QA and GCLP compliance.
  • Neil Steven
    Immunotherapy
  • Malcolm Taylor
    ATM biology
  • Benjamin Wilcox
    T cell receptor